...
首页> 外文期刊>Pharmacognosy magazine >Taxifolin Inhibits 7,12-Dimethylbenz(a)anthracene-induced Breast Carcinogenesis by Regulating AhR/CYP1A1 Signaling Pathway
【24h】

Taxifolin Inhibits 7,12-Dimethylbenz(a)anthracene-induced Breast Carcinogenesis by Regulating AhR/CYP1A1 Signaling Pathway

机译:Taxifolin通过调节AhR / CYP1A1信号通路抑制7,12-二甲基苯并(a)蒽诱导的乳腺癌致癌作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Breast cancer (BC), because of its invasive characteristics, is one of the most common and deadliest cancers among the female population around the world. Research has demonstrated that AhR signaling also plays a vital role in BC initiation and development as well. Therefore, blocking this pathway to natural interferences paves a new channel for the prevention of BC. Several natural compounds such as flavonoids possess the anticancer activities against different cancers. Objective: The present study has been designed to estimate the chemotherapeutic potential of taxifolin (TAX) against 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in Sprague-Dawley rats. Materials and Methods: Initially, the molecular docking analysis of AhR and cytochrome P450s (CYPs) (CYP1A1 and CYP1B1) was performed using MAESTRO tool, in an attempt to rationalize the activity of TAX, based on their CYP1-binding potential. The in vitro CYP1A1 activity was determined by luciferase assay with CYP1A1 substrate luciferin CEE. The in vivo analysis was performed by administrating TAX at 10, 20, 40 mg/kg BW for 28 days intragastrically in DMBA induced (25 mg/animal dose) at 55 days of age Sprague-Dawley (SD) rats. BC initiates after 90 days of tumor induction phase. The molecular mechanism of TAX on Ahr and CYPs was also examined through the mRNA and protein expressions using reverse transcription-quantitative polymerase chain reaction and Western blotting analysis. Results: Furthermore, TAX altered the energy regulation on DMBA-induced BC in SD rats by considerably restoring the cancer-induced modulations in tumor growth. Our results showed that TAX reduced the expressions of CYP1A1 and CYP1B1 in DMBA-induced mammary carcinoma by downregulating the AhR signaling pathway. Conclusion: This study revealed that TAX might be able to act as a chemotherapeutic agent against CYP1A1- and CYP1B1-mediated cancer and the inhibition of the DMBA-induced mammary carcinogenesis in a rat model. Abbreviations used: CYPs: Cytochrome P450s; PAH: polycyclic aromatic hydrocarbons; HRP- Horseradish peroxidase; BSA: Bovine serum albumin; DTTP: Deoxythymidine Triphosphate (nucleotide); RT-qPCR: Real Time quantitative polymerase chain reaction; CADD: Computer Aided Drug Drafting.
机译:背景:乳腺癌(BC)由于具有侵入性,是世界上女性人群中最常见,最致命的癌症之一。研究表明,AhR信号在BC的启动和发育中也起着至关重要的作用。因此,阻断这种自然干扰途径为预防BC铺平了新的渠道。几种天然化合物(例如黄酮类)具有针对不同癌症的抗癌活性。目的:本研究旨在评估紫杉醇(TAX)对7,12-二甲基苯并(a)蒽(DMBA)诱导的Sprague-Dawley大鼠乳癌的化学治疗潜力。材料和方法:最初,使用MAESTRO工具对AhR和细胞色素P450(CYP)(CYP1A1和CYP1B1)进行分子对接分析,试图根据其CYP1结合潜力合理化TAX的活性。体外CYP1A1活性通过使用CYP1A1底物荧光素CEE的荧光素酶测定法确定。体内分析是通过在55天大的Sprague-Dawley(SD)大鼠的DMBA诱导(25 mg /动物剂量)的胃内给予TAX 10、20、40 mg / kg BW连续28天来进行的。肿瘤诱导期90天后,BC开始。还使用逆转录-定量聚合酶链反应和蛋白质印迹分析,通过mRNA和蛋白质表达检查了TAX对Ahr和CYP的分子机制。结果:此外,TAX通过显着恢复癌症诱导的肿瘤生长调节,改变了SD大鼠DMBA诱导的BC的能量调节。我们的结果表明,TAX通过下调AhR信号通路降低了DMBA诱导的乳腺癌中CYP1A1和CYP1B1的表达。结论:本研究表明,TAX可能在大鼠模型中充当针对CYP1A1和CYP1B1介导的癌症的化学治疗剂,并抑制DMBA诱导的乳腺癌致癌作用。使用的缩写:CYP:细胞色素P450; PAH:多环芳烃; HRP-辣根过氧化物酶; BSA:牛血清白蛋白; DTTP:脱氧胸苷三磷酸(核苷酸); RT-qPCR:实时定量聚合酶链反应; CADD:计算机辅助药物起草。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号